Cargando…
Development of Recombinant Vaccine against A(H1N1) 2009 Influenza Based on Virus-like Nanoparticles Carrying the Extracellular Domain of M2 Protein
The conventional vaccines currently being used to deal with influenza are based on a virus obtained in chicken embryos or its components. The high variability of the major immunogenic surface proteins – hemagglutinin and neuraminidase–require the development of strain–specific vaccines that match th...
Autores principales: | Kotlyarov, R.Y., Kuprianov, V.V., Migunov, A.I., Stepanova, L.A., Tsybalova, L.M., Kiselev, O.I., Ravin, N.V., Skryabin, K.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347559/ https://www.ncbi.nlm.nih.gov/pubmed/22649643 |
Ejemplares similares
-
Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin
por: Stepanova, Liudmila A., et al.
Publicado: (2015) -
Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
por: Mardanova, Eugenia S., et al.
Publicado: (2015) -
Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide
por: Zykova, Anna A., et al.
Publicado: (2020) -
Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012) -
Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection
por: Zykova, Anna A., et al.
Publicado: (2023)